TY - JOUR
T1 - Benzodiazepine Sensitivity in Normal Human Subjects
AU - Hommer, Daniel W.
AU - Matsuo, Victor
AU - Wolkowitz, Owen
AU - Chrousos, Georgia
AU - Greenblatt, David J.
AU - Weingartner, Herbert
AU - Paul, Steven M.
PY - 1986/6
Y1 - 1986/6
N2 - Increasing intravenous doses of diazepam or placebo were administered to ten healthy normal volunteers, and the changes in saccadic eye velocity, self-rated sedation and anxiety, and plasma cortisol and growth hormone concentrations were measured. Diazepam administration (4.4 to 140 μg/kg, cumulative dose) resulted in a dose-dependent decrease in saccadic eye velocity and plasma cortisol level as well as a dose-dependent increase in self-rated sedation and plasma growth hormone level. Self-rated anxiety was unaffected in these relatively nonanxious subjects. The diazepam-induced changes in saccadic eye velocity, sedation, and growth hormone and cortisol levels were highly correlated with each other and with increasing plasma diazepam concentration. These results are consistent with a benzodiazepine receptor—mediated action of diazepam. The highly quantifiable and dose-dependent decrease in saccadic eye velocity by benzodiazepines should make this a useful measure of benzodiazepine receptor sensitivity in humans.
AB - Increasing intravenous doses of diazepam or placebo were administered to ten healthy normal volunteers, and the changes in saccadic eye velocity, self-rated sedation and anxiety, and plasma cortisol and growth hormone concentrations were measured. Diazepam administration (4.4 to 140 μg/kg, cumulative dose) resulted in a dose-dependent decrease in saccadic eye velocity and plasma cortisol level as well as a dose-dependent increase in self-rated sedation and plasma growth hormone level. Self-rated anxiety was unaffected in these relatively nonanxious subjects. The diazepam-induced changes in saccadic eye velocity, sedation, and growth hormone and cortisol levels were highly correlated with each other and with increasing plasma diazepam concentration. These results are consistent with a benzodiazepine receptor—mediated action of diazepam. The highly quantifiable and dose-dependent decrease in saccadic eye velocity by benzodiazepines should make this a useful measure of benzodiazepine receptor sensitivity in humans.
UR - http://www.scopus.com/inward/record.url?scp=0022547063&partnerID=8YFLogxK
U2 - 10.1001/archpsyc.1986.01800060032005
DO - 10.1001/archpsyc.1986.01800060032005
M3 - Article
C2 - 2871819
AN - SCOPUS:0022547063
SN - 0003-990X
VL - 43
SP - 542
EP - 551
JO - Archives of General Psychiatry
JF - Archives of General Psychiatry
IS - 6
ER -